94 related articles for article (PubMed ID: 8260237)
21. Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: the experience of the AIEOP Cooperative Study. Associazione Italiana Ematologia Oncologia Pediatrica.
Basso G; Rondelli R; Putti MC; Cantù Rajnoldi A; Granchi D; Cocito MG; Saitta M; Santostasi T; Guglielmi C; Lippi A
Recent Results Cancer Res; 1993; 131():297-307. PubMed ID: 8210648
[No Abstract] [Full Text] [Related]
22. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
Aricò M; Valsecchi MG; Rizzari C; Barisone E; Biondi A; Casale F; Locatelli F; Lo Nigro L; Luciani M; Messina C; Micalizzi C; Parasole R; Pession A; Santoro N; Testi AM; Silvestri D; Basso G; Masera G; Conter V
J Clin Oncol; 2008 Jan; 26(2):283-9. PubMed ID: 18182669
[TBL] [Abstract][Full Text] [Related]
23. [Therapeutic effectiveness of CCLG-97 protocol on standard-risk childhood acute lymphoblastic leukemia].
Xiao PF; Chai YH; Li JQ; He HL; Wang Y; Li ZP; He YX; Ji ZH
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):486-9. PubMed ID: 16083544
[TBL] [Abstract][Full Text] [Related]
24. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
Amadori S; Testi AM; Aricò M; Comelli A; Giuliano M; Madon E; Masera G; Rondelli R; Zanesco L; Mandelli F
J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
[TBL] [Abstract][Full Text] [Related]
25. Improved outcome of acute lymphoblastic leukaemia treated by delayed intensification in Hong Kong children: HKALL97 study.
Li CK; Chik KW; Ha SY; Lee AC; Yuen HL; Ling SC; Lee V; Chan GC; Shing MM; Chan LC; Ng MH
Hong Kong Med J; 2006 Feb; 12(1):33-9. PubMed ID: 16495587
[TBL] [Abstract][Full Text] [Related]
26. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
[TBL] [Abstract][Full Text] [Related]
27. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002.
Stary J; Zimmermann M; Campbell M; Castillo L; Dibar E; Donska S; Gonzalez A; Izraeli S; Janic D; Jazbec J; Konja J; Kaiserova E; Kowalczyk J; Kovacs G; Li CK; Magyarosy E; Popa A; Stark B; Jabali Y; Trka J; Hrusak O; Riehm H; Masera G; Schrappe M
J Clin Oncol; 2014 Jan; 32(3):174-84. PubMed ID: 24344215
[TBL] [Abstract][Full Text] [Related]
28. [The fate of children after discontinuation of treatment for acute lymphoblastic leukemia].
Derulska D; Rokicka-Milewska R; Jackowska T; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Cyklis R; Darmal B; Jakowicka M
Acta Haematol Pol; 1991; 22(2):223-32. PubMed ID: 1841493
[TBL] [Abstract][Full Text] [Related]
29. Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.
Pillon M; Mussolin L; Carraro E; Conter V; Aricò M; Vinti L; Garaventa A; Piglione M; Buffardi S; Sala A; Santoro N; Lo Nigro L; Mura R; Tondo A; Casale F; Farruggia P; Pierani P; Cesaro S; d'Amore ES; Basso G
Br J Haematol; 2016 Nov; 175(3):467-475. PubMed ID: 27392319
[TBL] [Abstract][Full Text] [Related]
30. A second course of treatment for childhood acute lymphoblastic leukaemia: long-term follow-up is needed to assess results.
Chessells JM; Leiper AD; Richards SM
Br J Haematol; 1994 Jan; 86(1):48-54. PubMed ID: 8011547
[TBL] [Abstract][Full Text] [Related]
31. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M;
Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410
[TBL] [Abstract][Full Text] [Related]
32. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study .
Ritchey AK; Pollock BH; Lauer SJ; Andejeski Y; Barredo J; Buchanan GR
J Clin Oncol; 1999 Dec; 17(12):3745-52. PubMed ID: 10577846
[TBL] [Abstract][Full Text] [Related]
33. Malignant sacrococcygeal germ cell tumors in childhood: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
D'Angelo P; De Pasquale MD; Barretta F; Affinita MC; Conte M; Dall'Igna P; Di Cataldo A; Inserra A; Provenzi M; Quaglietta L; Riccipetitoni G; Spreafico F; Trizzino A; Terenziani M;
Pediatr Blood Cancer; 2021 Mar; 68(3):e28812. PubMed ID: 33219741
[TBL] [Abstract][Full Text] [Related]
34. Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.
Wheeler K; Chessells JM; Bailey CC; Richards SM
Arch Dis Child; 1996 Feb; 74(2):101-7. PubMed ID: 8660070
[TBL] [Abstract][Full Text] [Related]
35. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S;
Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289
[TBL] [Abstract][Full Text] [Related]
36. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.
Balduzzi A; Valsecchi MG; Uderzo C; De Lorenzo P; Klingebiel T; Peters C; Stary J; Felice MS; Magyarosy E; Conter V; Reiter A; Messina C; Gadner H; Schrappe M
Lancet; 2005 Aug 20-26; 366(9486):635-42. PubMed ID: 16112299
[TBL] [Abstract][Full Text] [Related]
38. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
Veerman AJ; Kamps WA; van den Berg H; van den Berg E; Bökkerink JP; Bruin MC; van den Heuvel-Eibrink MM; Korbijn CM; Korthof ET; van der Pal K; Stijnen T; van Weel Sipman MH; van Weerden JF; van Wering ER; van der Does-van den Berg A;
Lancet Oncol; 2009 Oct; 10(10):957-66. PubMed ID: 19747876
[TBL] [Abstract][Full Text] [Related]
39. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
Chessells JM; Bailey C; Richards SM
Lancet; 1995 Jan; 345(8943):143-8. PubMed ID: 7823668
[TBL] [Abstract][Full Text] [Related]
40. [The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group].
Chybicka A; Bogusławska-Jaworska J; Gorczyńska E; Juszczak K; Armata J; Balcerska A; Balwierz W; Bubała H; Filiks-Litwin B; Kołecki P; Kowalczyk J; Lukowska K; Matysiak M; Rokicka-Milewska R; Rola-Kurc E; Stencel D; Sońta-Jakimczyk D; Strojny W; Wachowiak J; Wieczorek M; Wysocki M; Zelenay E
Wiad Lek; 1998; 51 Suppl 4():25-32. PubMed ID: 10731940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
